SSA
SYNH

Schonfeld Strategic Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,000
Closed -$2.5K – 2484
2023
Q2 		$2.5K Buy
+25,000
New +$1.01M ﹤0.01% 1982

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Schonfeld Strategic Advisors's SYNH Position: Q3 2023 in Review

Schonfeld Strategic Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 189,671 shares — an estimated $7.99M sold.

Schonfeld Strategic Advisors first reported a position in SYNH in Q2 2016 and held it in 10 quarters. The position peaked at $20.4M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Schonfeld Strategic Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 189,671 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $7.99M.
  • Schonfeld Strategic Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and held it in 10 quarters.
  • Schonfeld Strategic Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $20.4M in Q2 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.